Publicaciones en las que colabora con Esteban Ribera Pascuet (7)

2021

  1. HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

    Journal of Biomedical Science, Vol. 28, Núm. 1

2020

  1. Factors associated with the number of drugs in darunavir/cobicistat regimens

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 208-214

2016

  1. Impact of low-level viraemia on virological failure in HIV-1-infected patients with stable antiretroviral treatment

    Antiviral Therapy, Vol. 21, Núm. 4, pp. 345-352

2015

  1. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

  2. Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patients

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 11, pp. 6782-6790

  3. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792

2014

  1. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent hiv-infected patients in Spain

    AIDS Patient Care and STDs, Vol. 28, Núm. 10, pp. 537-542